EllenRx®Dermatology

Stelara denied by insurance? What insurers ask for and how to appeal

ustekinumab · Sources reviewed Nov 10, 2026 · Sources below

Used for
4 conditions (see above)
How it's given
IV infusion, then injection under the skin
Prior authorization usually required?
Varies by plan

What does my insurer usually ask for before approving Stelara?

  • Not combined with other biologic drugsPlans will not pay for Stelara together with another biologic or targeted drug for the same condition.
  • For psoriasis: tried light therapy or pills firstPlans want to see that light therapy or a standard pill like methotrexate did not work well enough, unless you cannot use them.
  • Prescribed by or with a specialistPlans want a specialist for your condition, such as a skin, joint, or stomach doctor, to prescribe or advise.
  • TB test before startingStelara can raise the risk of tuberculosis, so the label and plans call for a TB check before your first dose.
  • For Crohn's or colitis: first dose by IVFor Crohn's disease and ulcerative colitis, Stelara starts with one IV infusion, and plans approve the shots for after that first dose.
  • Your plan may prefer a certain versionSeveral ustekinumab biosimilars exist, and some plans cover only preferred versions, which may not include brand Stelara.

Based on published policies from several large commercial insurers and the FDA label (see Sources). Medicare, Medicaid and other plans may use different rules. Your plan's rules may differ.

Why was Stelara denied, and what can I do?

  1. Decode your denial letter: Ellen explains the reason in plain words.
  2. Check your denial type and your rights (Medicare or Medicaid if that's your coverage).
  3. Build your appeal, with the step-by-step appeal guide.
Decode my Stelara denial

How can I lower the cost of Stelara?

If you have Medicare or Medicaid, check each program's terms before you apply.

How does Stelara compare?

Safety information

From FDA-approved prescribing information for Stelara (IL-12/23 Inhibitor).

Do not use if

  • Clinically significant hypersensitivity to ustekinumab

Key warnings

  • Evaluate for TB before starting
  • May increase risk of infections
  • Reversible posterior leukoencephalopathy syndrome (RPLS) reported rarely

This is not a complete list. See the full Stelara prescribing information or ask your pharmacist for complete safety information.

For clinicians: Stelara prior authorization card (printable).

Sources: FDA prescribing information for Stelara (DailyMed) and these insurers' published policies: Aetna (CPB 0912, last review 10/14/2026), Anthem/Elevance (Publish date 09/10/2025; last review 08/15/2025), Cigna (Effective 10/01/2026), UnitedHealthcare (Effective 9/1/2026). Checked 2026-11-10. Sources reviewed Nov 10, 2026.

Not medical advice. This page is for educational and informational purposes only. It does not replace professional medical judgment. Always consult your prescribing physician or pharmacist before starting, stopping, or changing any medication. Ellen does not provide medical advice, diagnose conditions, or recommend treatments. Coverage rules vary by plan and change often; confirm with your plan's current policy.